AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Antipsychotic dosing patterns for schizophrenia in three treatment settings
Authors: Remington, G Shammi, CM Sethna, R Lawrence, R
Citation: G. Remington et al., Antipsychotic dosing patterns for schizophrenia in three treatment settings, PSYCH SERV, 52(1), 2001, pp. 96-98
Atypical antipsychotics (vol 321, pg 1360, 2000)
Authors: Kapur, S Remington, G
Citation: S. Kapur et G. Remington, Atypical antipsychotics (vol 321, pg 1360, 2000), BR MED J, 322(7278), 2001, pp. 90-90
Electroconvulsive therapy in cases of treatment-resistant psychosis
Authors: Parker, V Remington, G
Citation: V. Parker et G. Remington, Electroconvulsive therapy in cases of treatment-resistant psychosis, CAN J PSY, 46(8), 2001, pp. 762-763
Health care utilization in patients with schizophrenia maintained on atypical versus conventional antipsychotics
Authors: Remington, G Khramov, I
Citation: G. Remington et I. Khramov, Health care utilization in patients with schizophrenia maintained on atypical versus conventional antipsychotics, PROG NEUR-P, 25(2), 2001, pp. 363-369
Clomipramine versus haloperidol in the treatment of autistic disorder: A double-blind, placebo-controlled, crossover study
Authors: Remington, G Sloman, L Konstantareas, M Parker, K Gow, R
Citation: G. Remington et al., Clomipramine versus haloperidol in the treatment of autistic disorder: A double-blind, placebo-controlled, crossover study, J CL PSYCH, 21(4), 2001, pp. 440-444
Awareness of tardive dyskinesia in Asian patients with schizophrenia
Authors: Chong, SA Remington, G Mahendran, R Chua, HC
Citation: Sa. Chong et al., Awareness of tardive dyskinesia in Asian patients with schizophrenia, J CL PSYCH, 21(2), 2001, pp. 235-237
Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia
Authors: Kapur, S Remington, G
Citation: S. Kapur et G. Remington, Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia, ANN R MED, 52, 2001, pp. 503-517
Psychopharmacology of antidepressants
Authors: Remington, G
Citation: G. Remington, Psychopharmacology of antidepressants, AM J PSYCHI, 158(9), 2001, pp. 1538-1538
Psychopharmacology of antipsychotics
Authors: Remington, G
Citation: G. Remington, Psychopharmacology of antipsychotics, AM J PSYCHI, 158(9), 2001, pp. 1538-1538
A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia
Authors: Azorin, JM Spiegel, R Remington, G Vanelle, JM Pere, JJ Giguere, M Bourdeix, I
Citation: Jm. Azorin et al., A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia, AM J PSYCHI, 158(8), 2001, pp. 1305-1313
Increased dopamine D-2 receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine
Authors: Kapur, S Roy, P Daskalakis, J Remington, G Zipursky, R
Citation: S. Kapur et al., Increased dopamine D-2 receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine, AM J PSYCHI, 158(2), 2001, pp. 311-314
Predicting haloperidol occupancy of central dopamine D-2 receptors from plasma levels
Authors: Fitzgerald, PB Kapur, S Remington, G Roy, P Zipursky, RB
Citation: Pb. Fitzgerald et al., Predicting haloperidol occupancy of central dopamine D-2 receptors from plasma levels, PSYCHOPHAR, 149(1), 2000, pp. 1-5
Atypical antipsychotics: are some more atypical than others?
Authors: Remington, G Kapur, S
Citation: G. Remington et S. Kapur, Atypical antipsychotics: are some more atypical than others?, PSYCHOPHAR, 148(1), 2000, pp. 3-15
Atypical antipsychotics - Patients value the lower incidence of extrapyramidial side effects
Authors: Kapur, S Remington, G
Citation: S. Kapur et G. Remington, Atypical antipsychotics - Patients value the lower incidence of extrapyramidial side effects, BR MED J, 321(7273), 2000, pp. 1360-1361
Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D-2 blockade
Authors: Fitzgerald, PB Kapur, S Caligiuri, MP Jones, C Silvestri, S Remington, G Zipursky, RB
Citation: Pb. Fitzgerald et al., Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D-2 blockade, NEUROPSYCH, 22(1), 2000, pp. 19-26
Schizophrenia: Building and fixing scientific models
Authors: Remington, G
Citation: G. Remington, Schizophrenia: Building and fixing scientific models, CAN J PSY, 45(3), 2000, pp. 239-240
Are animal studies of antipsychotics appropriately dosed?: Lessons from the bedside to the bench
Authors: Kapur, S Wadenberg, ML Remington, G
Citation: S. Kapur et al., Are animal studies of antipsychotics appropriately dosed?: Lessons from the bedside to the bench, CAN J PSY, 45(3), 2000, pp. 241-246
Clozapine augmentation: Safety and efficacy
Authors: Chong, SA Remington, G
Citation: Sa. Chong et G. Remington, Clozapine augmentation: Safety and efficacy, SCHIZO BULL, 26(2), 2000, pp. 421-440
A positron emission tomography study of quetiapine in schizophrenia - A preliminary finding of an antipsychotic effect with only transiently high dopamine D-2 receptor occupancy
Authors: Kapur, S Zipursky, R Jones, C Shammi, CS Remington, G Seeman, P
Citation: S. Kapur et al., A positron emission tomography study of quetiapine in schizophrenia - A preliminary finding of an antipsychotic effect with only transiently high dopamine D-2 receptor occupancy, ARCH G PSYC, 57(6), 2000, pp. 553-559
Relationship between dopamine D-2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia
Authors: Kapur, S Zipursky, R Jones, C Remington, G Houle, S
Citation: S. Kapur et al., Relationship between dopamine D-2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia, AM J PSYCHI, 157(4), 2000, pp. 514-520
Conventional versus novel antipsychotics: changing concepts and clinical implications
Authors: Remington, G Chong, SA
Citation: G. Remington et Sa. Chong, Conventional versus novel antipsychotics: changing concepts and clinical implications, J PSYCH NEU, 24(5), 1999, pp. 431-441
Where do the "old" antipsychotics fit in today's treatment plans?
Authors: Remington, G
Citation: G. Remington, Where do the "old" antipsychotics fit in today's treatment plans?, J PSYCH NEU, 24(2), 1999, pp. 192-192
Plasma olanzapine and clinical response
Authors: Chong, SA Remington, G
Citation: Sa. Chong et G. Remington, Plasma olanzapine and clinical response, J CL PSYCH, 19(2), 1999, pp. 192-193
Risperidone treatment of tardive dyskinesia and dystonia
Authors: Chong, SA Remington, G Tan, CH
Citation: Sa. Chong et al., Risperidone treatment of tardive dyskinesia and dystonia, J CLIN PSY, 60(5), 1999, pp. 340-341
D-2 and 5-HT2 receptor effects of antipsychotics: Bridging basic and clinical findings using PET
Authors: Remington, G Kapur, S
Citation: G. Remington et S. Kapur, D-2 and 5-HT2 receptor effects of antipsychotics: Bridging basic and clinical findings using PET, J CLIN PSY, 60, 1999, pp. 15-19
Risultati: 1-25 | 26-27